Cetera Investment Advisers Synlogic, Inc. Transaction History

Cetera Investment Advisers

  • $44.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
BUY
$0.42 - $0.68 $4,553 - $7,372
10,842 Added 47.04%
33,890 $14,000
Q1 2023

May 15, 2023
BUY
$0.56 - $1.07 $4,275 - $8,168
7,634 Added 49.53%
23,048 $14,000
Q4 2022

Feb 14, 2023
BUY
$0.58 - $17.99 $8,940 - $277,297
15,414 New
15,414 $11,000

Others Institutions Holding SYBX

# of Institutions
2
Shares Held
25.5K
Call Options Held
0
Put Options Held
0
View Full List

About SYNLOGIC, INC.

SYBX Quotes by TradingView
  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $101M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email